Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.
Nu Skin Enterprises, Inc. reports developments tied to its beauty and wellness business, affiliate opportunity platform and international market operations. Company updates commonly cover quarterly revenue and earnings, customer, paid affiliate and sales leader trends, dividend declarations, cost discipline and product commercialization across Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging brands.
Recurring news also includes the rollout of Prysm iO, an intelligent wellness platform that uses skin scans to provide antioxidant-related insights, and activity at Rhyz, the company’s strategic investment arm for consumer, technology and manufacturing businesses in beauty, wellness and lifestyle categories. Leadership appointments and operating-structure changes are also part of the company’s public updates.
Nu Skin (NYSE: NUS) announced the relaunch of Dr. Joseph Chang’s bestselling book The Aging Myth with 15 years of additional research on measurable biology and cellular wellness.
The updated edition links expanded chapters on cellular resilience, oxidative stress, and measurable biomarkers to Nu Skin’s Prysm iO platform and ageLOC technologies. The digital edition is available today for $9.99 on major retailers.
Stonegate Capital Partners attended the ICR 2026 conference in Dallas on January 14, 2026, where it moderated a fireside chat with Nu Skin (NASDAQ: NUS). Stonegate also attended presentations from LifeVantage (LFVN), USANA (USNA), Beachbody (BODI) and Strauss Group (STRS), and observed an RSM panel on "cutting through the AI hype." The release notes common themes across retail, hybrid and DTC go-to-market models in nutrition, beauty and wellness sectors and points readers to the full announcement for images and bios.
Nu Skin Enterprises (NYSE:NUS) will release its fourth quarter and full year 2025 financial results after the market closes on Thursday, Feb. 12, 2026. The management team will host a conference call the same day at 5:00 p.m. ET to discuss recent results and upcoming business initiatives. A live webcast of the call and the financial presentation will be available on the company investor relations site at ir.nuskin.com. A replay will remain available through Thursday, Feb. 26, 2026.
Nu Skin (NYSE: NUS) announced that president and CEO Ryan Napierski will participate in a moderated fireside chat at the ICR Conference on Monday, Jan. 12, 2026 to discuss company strategy and the state of the business. The discussion will cover 2026 plans to launch the Prysm iO intelligent wellness device and growth opportunities in emerging markets, including India. The event will be webcast live at 1:30 p.m. ET, with an archive available on the company investor relations site through Monday, Jan. 26, 2026.
Nu Skin (NYSE: NUS) released its 2024 Social Impact and Sustainability Report outlining philanthropy and environmental progress. Highlights include $4.6 million donated globally, 1,400 children's heart surgeries performed in 2024 (part of >32,000 since 1999), and 30 million meals purchased and donated through Nourish the Children in 2024 (totaling >850 million since 2002).
On sustainability, Nu Skin reports reducing 8.5 tons of plastic and 1.4 tons of paper, using >24 tons of recycled plastic and 100% RSPO sourcing for palm ingredients, and a goal to make all product packaging recycled, recyclable, reusable, reduced or renewable by 2030. The company received 37 awards for sustainability and social impact.
Nu Skin (NYSE: NUS) launched Prysm iO, an AI-powered, portable skin-scanning platform that measures carotenoid antioxidant levels via a finger scan and delivers a personalized Prysm Score. Built on 20+ years of carotenoid research and a database of >21 million scans, Prysm iO uses patent-pending Spectral Rai Technology and AI algorithms. A Nu Skin randomized, double-blind, placebo-controlled study (n=46) reported 43–46% skin carotenoid increases over 12 weeks and serum increases of 44% vitamin C and 26% selenium. Device rollout: qualified brand representatives in Q4 2025, broader consumer availability in early to mid-2026.
Nu Skin Enterprises (NYSE: NUS) reported Q3 2025 revenue of $364.2 million and GAAP EPS of $0.34 versus $0.17 a year ago, with results within guidance.
Key metrics: revenue down ~15.3% YoY (or ~11.5% excl. Mavely 2024), gross margin improved to 70.5%, operating margin 5.9%, and customers declined to 746,256. Management announced a limited Prysm iO sales leader preview in late Q4 and pre-market opening activities in India ahead of a 2026 consumer launch.
Capital returns: $5.0 million repurchased in Q3 and $152.4 million remaining authorization. Q4 revenue guide: $365–$400M; 2025 revenue guide: $1.48–$1.51B; 2025 EPS guide: $3.15–$3.25 (adjusted EPS $1.25–$1.35).
Nu Skin Enterprises (NYSE:NUS) announced its board declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on Dec. 10, 2025 to shareholders of record on Nov. 28, 2025. This is a discrete cash distribution to eligible shareholders.
Nu Skin (NYSE: NUS) will release third quarter 2025 financial results after the market closes on Thursday, Nov. 6, 2025.
Management will host a conference call with the investment community the same day at 5:00 p.m. ET to discuss recent results and upcoming business initiatives. A live webcast, including the financial presentation, will be available on the company investor relations site at ir.nuskin.com, with a replay accessible through Thursday, Nov. 20, 2025.
Nu Skin (NYSE: NUS) has maintained its position as the world's #1 company for beauty and wellness device systems, according to Euromonitor International Ltd., marking its second consecutive year at the top. The company announced plans to expand its product portfolio with the Prysm iO intelligent wellness device, scheduled for limited release in late 2025.
The upcoming Prysm iO device will utilize AI capabilities and a database of 20 million scans over 20 years to measure skin carotenoid levels non-invasively, providing insights into antioxidant levels and supplement absorption. The company's current portfolio includes several innovative devices such as ageLOC LumiSpa iO, RenuSpa iO, WellSpa iO, and other specialized beauty and wellness products.